Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RN-0001 for Early Treatment of Acute Pancreatitis with SIRS (Phase II, China)
CTR20255236Phase 2Active
- Sponsor
- Ruinuo Medical Technology
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RN-0001 in acute pancreatitis (AP), Systemic Inflammatory Response Syndrome (SIRS), sponsored by Ruinuo Medical Technology. Started Jan 2026; status: active.
02
Drugs
RN-0001
03
Conditions
acute pancreatitis (AP)Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on CTR20255236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255236.